Portage Biotech Stock (NASDAQ: PRTG) stock price, news, charts, stock research, profile.
Open | $4.25 |
Close | $6.00 |
Volume / Avg. | 49.67M / 101.31K |
Day Range | $3.90 - $8.28 |
52 Wk Range | 2.10 - 61.99 |
Market Cap | $6.04M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 69 |
Short Interest | 8.58% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Portage Biotech (NASDAQ:PRTG) through any online brokerage.
Other companies in Portage Biotech’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA), Quoin Pharmaceuticals (NASDAQ:QNRX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
Portage Biotech has a consensus price target of $24.75.
The stock price for Portage Biotech (NASDAQ: PRTG) is $5.76 last updated August 23, 2024 at 7:59 PM EDT.
There are no upcoming dividends for Portage Biotech.
Portage Biotech’s Q1 earnings are confirmed for Friday, September 6, 2024.
There is no upcoming split for Portage Biotech.
Portage Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.